Table 4 Clinical, laboratory, and ultrasonography assessments at baseline and follow-up according to baseline eGFR categories.

From: Estimated glomerular filtration rate and cardiometabolic risk factors in a longitudinal cohort of children

 

Lower filtration (< 90 mL/min/1.73 m2)

Average filtration (90–119 mL/min/1.73 m2)

Higher filtration (≥ 120 mL/min/1.73 m2)

p value

N = 160

N = 197

N = 44

Baseline

eGFR (mL/min/1.73 m2)

80.2 ± 7.0bc

102.3 ± 7.7ac

130.8 ± 13.4ab

< 0.0001

Age (years)

7 ± 1bc

8 ± 2a

8 ± 2a

< 0.0001

Sex (female %)

49

54

57

NS

Puberty (%)

6

12

18

0.02

Overweight/obesity (%)

24

31

39

NS

BMI-SDS

0.2 ± 1.2

0.3 ± 1.3

0.6 ± 1.4

NS

Height-SDS

0.3 ± 1.1

0.5 ± 1.1

0.3 ± 1.4

NS

Weight-SDS

0.3 ± 1.2

0.5 ± 1.3

0.7 ± 1.6

NS

Waist (cm)

58.2 ± 10.1bc

63.3 ± 12.6a

66.8 ± 15.5a

< 0.0001

SBP (mmHg)

102.9 ± 8.9c

105.5 ± 11.0

108.1 ± 12.6a

0.007

DBP (mmHg)

58.5 ± 7.3c

60.0 ± 7.5

62.0 ± 6.7a

0.01

Hypertension (%)

4

5

7

NS

Creatinine (mg/dL)

0.57 ± 0.07bc

0.47 ± 0.06ac

0.38 ± 0.06ab

< 0.0001

Glucose (mg/dL)

85.4 ± 6.2

86.4 ± 6.8

86.4 ± 6.0

NS

Insulin (µU/mL)

3.3 ± 3.8bc

4.7 ± 4.6ac

6.8 ± 7.5ab

< 0.0001

HOMA-IR

0.7 ± 0.8bc

1.0 ± 0.9ac

1.4 ± 1.5ab

< 0.0001

HDL-cholesterol (mg/dL)

56.7 ± 11.8

58.4 ± 14.7

58.0 ± 15.3

NS

LDL-cholesterol (mg/dL)

84.7 ± 19.1c

94.1 ± 23.1

99.3 ± 27.8a

0.03

Total cholesterol (mg/dL)

169.7 ± 29.6

164.6 ± 26.8

170.5 ± 31.9

NS

Triacylglycerol (mg/dL)

58.4 ± 23.8

59.0 ± 31.3

63.8 ± 34.2

NS

Renal length (cm)

8.5 ± 0.8c

8.6 ± 0.9c

9.1 ± 1.2ab

0.005

Renal volume (cm3)

66.6 ± 18.7bc

76.3 ± 20.9ac

87.9 ± 34.4ab

< 0.0001

Follow-up

eGFR (mL/min/1.73 m2)

93.1 ± 11.3bc

103.2 ± 15.0ac

117.7 ± 17.5ab

< 0.0001

Age (years)

11 ± 2bc

12 ± 2a

13 ± 2a

< 0.0001

Puberty (%)

56

65

74

NS

Overweight/obesity (%)

22

32

36

NS

BMI-SDS

0.2 ± 1.2

0.4 ± 1.3

0.8 ± 1.8

NS

Height-SDS

0.3 ± 1.1

0.4 ± 1.0

0.1 ± 1.0

NS

Weight-SDS

0.3 ± 1.2

0.6 ± 1.3

0.7 ± 1.8

NS

Waist (cm)

70.8 ± 12.3bc

74.7 ± 13.9a

77.0 ± 18.4a

0.007

SBP (mmHg)

105.3 ± 11.8bc

112.4 ± 12.6a

115.2 ± 13.9a

< 0.0001

DBP (mmHg)

58.0 ± 7.8bc

62.1 ± 7.5a

61.5 ± 8.1a

< 0.0001

Hypertension (%)

1

4

2

NS

Glucose (mg/dL)

86.9 ± 5.8

87.0 ± 7.0

85.3 ± 7.6

NS

Creatinine (mg/dL)

0.61 ± 0.08c

0.60 ± 0.12c

0.54 ± 0.11ab

< 0.0001

Insulin (µU/mL)

6.3 ± 4.9bc

10.2 ± 6.4a

11.5 ± 7.2a

< 0.0001

HOMA-IR

1.3 ± 1.1bc

2.2 ± 1.4a

2.4 ± 1.6a

< 0.0001

HDL-cholesterol (mg/dL)

57.3 ± 12.5

57.2 ± 16.0

57.8 ± 18.3

NS

LDL-cholesterol (mg/dL)

78.7 ± 25.3

81.1 ± 22.2

87.1 ± 24.5

NS

Total cholesterol (mg/dL)

163.8 ± 28.4b

152.6 ± 28.8a

158.6 ± 28.4

0.001

Triacylglycerol (mg/dL)

60.2 ± 26.1c

67.4 ± 34.3

67.6 ± 30.6

NS

Renal length (cm)

9.4 ± 0.8bc

10.0 ± 1.0a

10.3 ± 1.4a

< 0.0001

Renal volume (cm3)

86.1 ± 26.2 bc

110.2 ± 35.6 a

124.2 ± 50.4 a

< 0.0001

  1. Data is presented as mean ± standard deviation (SD), or n (%).
  2. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR glomerular filtration rate, HOMA-IR homeostatic model assessment of insulin resistance, NS non-significant. Continuous variables are compared with the ANOVA and the Bonferroni test, and proportions are compared with the chi-square.
  3. ap < 0.05 compared to lower filtration.
  4. bp < 0.05 compared to average filtration.
  5. cp < 0.05 compared to higher filtration.
  6. Significant after adjustment for pubertal stage, sex, age, and BMI in univariate general linear models are shown in bold.